Kidney stones: pathophysiology and medical management. (Q34489092)

2 August 2017

1 reference

title

Kidney stones: pathophysiology and medical management. (English)

1 reference

2 August 2017

1 reference

Orson W Moe

1

1 reference

PubMed ID

16443041

2 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

2 August 2017

1 reference

2 August 2017

367

1 reference

2 August 2017

333-344

1 reference

2 August 2017

9507

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

2 August 2017

1 reference

7 January 2021

Factors influencing bladder stone formation in patients with spinal cord injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Time trends in reported prevalence of kidney stones in the United States: 1976-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

A prospective study of recurrence rate and risk factors for recurrence after a first renal stone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

The Natural History of Renal and Ureteric Calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Renal stone epidemiology: A 25-year study in Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Demographic and geographic variability of kidney stones in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Etiological role of estrogen status in renal stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Observations on the analysis of ten thousand urinary calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Urinary tract stone disease in the United States veteran population. I. Geographical frequency of occurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Predictive value of kidney stone composition in the detection of metabolic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Diagnosis of acute flank pain: value of unenhanced helical CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Retrospective study of 95 patients with staghorn calculus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Helical CT for Nephrolithiasis and Ureterolithiasis: Comparison of Conventional and Reduced Radiation-Dose Techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Spiral computed tomography: role in determination of chemical compositions of pure and mixed urinary stones--an in vitro study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Clinical implications of physicochemistry of stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

THE ORIGIN AND GROWTH OF RENAL CALCULI

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Urine calcium and volume predict coverage of renal papilla by Randall's plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Stone formation is proportional to papillary surface coverage by Randall's plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

The primary stone event: a new hypothesis involving a vascular etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

A Simple Test for the Diagnosis of Absorptive, Resorptive and Renal Hypercalciurias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Reduced vertebral bone density in hypercalciuric nephrolithiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Abnormal Bone Histology in Idiopathic Hypercalciuria *

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Selective effects of thiazide therapy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

The potential role of salt abuse on the risk for kidney stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Relation between urinary calcium and sodium in patients with idiopathic hypercalciuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Calcium Urolithiasis, Blood Pressure and Salt Intake

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Hypothesizing on the evolutionary origins of salt-induced hypercalciuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Bone buffering of acid and base in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

The Effect of High Animal Protein Intake on the Risk of Calcium Stone-Formation in the Urinary Tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Effect of high protein diet on stone-forming propensity and bone loss in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Citrate and renal calculi: new insights and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Pathophysiology of hypocitraturic nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Rapid Communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Hyperoxaluric calcium nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Effect of urate on calcium oxalate crystallization in human urine: evidence for a promotory role of hyperuricosuria in urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Hypercalciuria and Hyperuricosuria in Patients with Calcium Nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Nephrolithiasis in patients with gout

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Pathophysiology of uric acid nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Biochemical profile of idiopathic uric acid nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Pathophysiologic basis for normouricosuric uric acid nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Biochemical profile of stone-forming patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

High prevalence of uric acid calculi in diabetic stone formers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Association of urinary pH with body weight in nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Garrod's foresight; our hindsight

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Genetic hypercalciuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Familial idiopathic hypercalciuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Autosomal dominant inheritance of hypercalciuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Familial absorptive hypercalciuria in a large kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Influence of Calcium-Sensing Receptor Gene on Urinary Calcium Excretion in Stone-Forming Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

No evidence for point mutations of the calcium-sensing receptor in familial idiopathic hypercalciuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Molecular etiology of primary hyperoxaluria type 1: new directions for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Identification of a new candidate locus for uric acid nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Identification of a novel gene and a common variant associated with uric acid nephrolithiasis in a Sardinian genetic isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

The amino acid transport system b(o,+) and cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Surgical management of urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Expanding role of ureteroscopy and laser lithotripsy for treatment of proximal ureteral and intrarenal calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Percutaneous nephrolithotomy: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Ureteroscopic treatment of renal calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Factitious renal colic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Clinical practice. Acute renal colic from ureteral calculus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Beverage use and risk for kidney stones in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

High salt intake appears to increase bone resorption in postmenopausal women but high potassium intake ameliorates this adverse effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Pathogenesis of hypercalciuric nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

The influence of calcium content of water, intake of vegetables and fruit and of other food factors upon the incidence of renal calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Dependence of oxalate absorption on the daily calcium intake

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Contribution of dietary oxalate to urinary oxalate excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

A further study of oxalate bioavailability in foods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Meta-Analysis of Randomized Trials for Medical Prevention of Calcium Oxalate Nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Successful management of uric acid nephrolithiasis with potassium citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Struvite stones: diagnosis and current treatment concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968071-9

7 January 2021

10.1016/S0140-6736(06)68071-9

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

16443041